HK1168005A1 - Methods for preventing and or treating degenerative disorders of the central nervous system - Google Patents

Methods for preventing and or treating degenerative disorders of the central nervous system

Info

Publication number
HK1168005A1
HK1168005A1 HK12108930.2A HK12108930A HK1168005A1 HK 1168005 A1 HK1168005 A1 HK 1168005A1 HK 12108930 A HK12108930 A HK 12108930A HK 1168005 A1 HK1168005 A1 HK 1168005A1
Authority
HK
Hong Kong
Prior art keywords
preventing
methods
nervous system
central nervous
degenerative disorders
Prior art date
Application number
HK12108930.2A
Other languages
English (en)
Chinese (zh)
Inventor
Robert Boyd
Gary Lee
Original Assignee
阿米庫斯治療學公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 阿米庫斯治療學公司 filed Critical 阿米庫斯治療學公司
Publication of HK1168005A1 publication Critical patent/HK1168005A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK12108930.2A 2009-04-09 2012-09-12 Methods for preventing and or treating degenerative disorders of the central nervous system HK1168005A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16810109P 2009-04-09 2009-04-09
PCT/US2010/030470 WO2010118282A1 (en) 2009-04-09 2010-04-09 Methods for preventing and/or treating degenerative disorders of the central nervous system

Publications (1)

Publication Number Publication Date
HK1168005A1 true HK1168005A1 (en) 2012-12-21

Family

ID=42934882

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12108930.2A HK1168005A1 (en) 2009-04-09 2012-09-12 Methods for preventing and or treating degenerative disorders of the central nervous system

Country Status (12)

Country Link
US (1) US8304429B2 (es)
EP (1) EP2416655B1 (es)
JP (1) JP5634498B2 (es)
CN (1) CN102448306B (es)
AU (1) AU2010233187B2 (es)
BR (1) BRPI1015472A2 (es)
CA (1) CA2758187C (es)
ES (1) ES2505243T3 (es)
HK (1) HK1168005A1 (es)
IL (1) IL215584A (es)
NZ (1) NZ595630A (es)
WO (1) WO2010118282A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5645918B2 (ja) * 2009-04-09 2014-12-24 アミカス セラピューティックス インコーポレイテッド リソソーム蓄積障害の予防および／または治療方法
HUE028129T2 (en) 2009-10-19 2016-11-28 Amicus Therapeutics Inc New preparations for the prevention and / or treatment of lysosomal storage disorders
WO2011049736A1 (en) 2009-10-19 2011-04-28 Amicus Therapeutics, Inc. Novel compositions for preventing and/or treating degenerative disorders of the central nervous system
WO2012068405A2 (en) 2010-11-17 2012-05-24 Isis Pharmaceuticals, Inc. Modulation of alpha synuclein expression
WO2013070981A2 (en) * 2011-11-08 2013-05-16 University Of Central Florida Research Foundation, Inc. Treating er stress related disorders by stabilizing intracellular calcium homeostasis
US9155695B2 (en) 2013-03-14 2015-10-13 Medtronic, Inc. Injectable ropinirole compositions and methods for making and using same
US9796680B2 (en) 2013-12-23 2017-10-24 Alectos Therapeutics Inc. Glucocerebrosidase modulators and uses thereof
GB201512203D0 (en) 2015-07-13 2015-08-19 Lundbeck & Co As H Agents,uses and methods
US10300155B2 (en) 2015-12-31 2019-05-28 Washington University Alpha-synuclein ligands
CA3036511A1 (en) * 2016-09-12 2018-03-15 Steven Hoffman Compositions for treating dementia
BR112018014281A2 (pt) * 2016-11-15 2018-12-18 H Lundbeck As agentes, usos e métodos para o tratamento da sinucleinopatia
WO2019140231A1 (en) 2018-01-12 2019-07-18 Bristol-Myers Squibb Company Antisense oligonucleotides targeting alpha-synuclein and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69531098T2 (de) * 1994-03-09 2004-04-29 Novo Nordisk A/S Piperidine und pyrrolidine
US20060079533A1 (en) * 2001-03-23 2006-04-13 Nieman James A Methods of treating alzheimer's disease
US6770625B2 (en) 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US6670625B1 (en) * 2002-06-18 2003-12-30 Ge Medical Systems Global Technology Company, Llc Method and apparatus for correcting multipole aberrations of an electron beam in an EBT scanner
JP2006507359A (ja) * 2002-10-28 2006-03-02 ノボ・ノルデイスク・エー／エス 心循環器疾患の治療のためのグリコーゲンホスホリラーゼ阻害剤の使用
EP1888068B1 (en) * 2005-06-08 2014-05-21 Amicus Therapeutics, Inc. Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes
WO2007150064A2 (en) * 2006-06-23 2007-12-27 Amicus Therapeutics, Inc. METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF β-GLUCOCEREBROSIDASE
US20080009156A1 (en) 2006-07-10 2008-01-10 Malin Glen K System and method for bonding coaxial cable
JP5645918B2 (ja) * 2009-04-09 2014-12-24 アミカス セラピューティックス インコーポレイテッド リソソーム蓄積障害の予防および／または治療方法

Also Published As

Publication number Publication date
EP2416655A4 (en) 2012-09-05
US8304429B2 (en) 2012-11-06
JP5634498B2 (ja) 2014-12-03
NZ595630A (en) 2013-04-26
CA2758187A1 (en) 2010-10-14
AU2010233187B2 (en) 2015-10-08
BRPI1015472A2 (pt) 2015-11-24
EP2416655B1 (en) 2014-06-25
JP2012523430A (ja) 2012-10-04
IL215584A0 (en) 2011-12-29
WO2010118282A1 (en) 2010-10-14
US20100261753A1 (en) 2010-10-14
EP2416655A1 (en) 2012-02-15
ES2505243T3 (es) 2014-10-09
AU2010233187A1 (en) 2011-11-03
IL215584A (en) 2016-11-30
CA2758187C (en) 2017-03-07
CN102448306A (zh) 2012-05-09
CN102448306B (zh) 2014-07-02

Similar Documents

Publication Publication Date Title
HK1168005A1 (en) Methods for preventing and or treating degenerative disorders of the central nervous system
HRP20170236T1 (hr) Novi pripravci za sprječavanje i/ili liječenje degenerativnih poremećaja središnjeg živčanog sustava
EP2485797A4 (en) DEVICES, SYSTEMS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS AND DISORDERS
EP2379559A4 (en) PYRIMIDO DIAZEPINONE KINASE FERTILIZERS AND METHOD FOR THE TREATMENT OF ILLNESSES
GB201001047D0 (en) Methods and compositions for the treatment of neurological disorders
SI2430022T1 (sl) 1,2,3-triazolo(4,3-a)piridin derivati in njihova uporaba za zdravljenje ali prepreäśevanje nevroloĺ kih in psihiatriäśnih nepravilnosti
EP2552433A4 (en) COMPOSITIONS AND METHODS OF TREATING SOMATOSENSORY DISEASES
IL213526A0 (en) Methods for treating acute myocardial infarctions and associated disorders
EP2170309A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES
EP2331088A4 (en) COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC ILLNESSES
IL204785A0 (en) Systems and methods for treatment of medical conditions related to the central nervous system and for enhancing cognitive functions
GB2467710B (en) Methods for treating social disorders
GB2495885B (en) Combination pharmaceutical composition and methods of treating genitourinary system disorders
EP2550361A4 (en) COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDER
HK1199831A1 (en) Composition for improving and or treating central nervous system degenerative disease
EP2672996A4 (en) METHOD AND SYSTEMS FOR TREATING OR PREVENTING PREGNANT BLOOD PRESSURE DRESSING
EP2618826A4 (en) PHENYLPIPERIDINE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
HK1205503A1 (en) Novel compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system //
EP2612668A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF DEGENERATIVE NEUROLOGICAL CEREBRAL DISORDERS
EP2582832A4 (en) METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CENTRAL ANIMAL NERVOUS SYSTEM FOR PSYCHIATRIC DISORDERS
SI2278962T1 (sl) Postopki za zdravljenje dermatoloških motenj
EP2190981A4 (en) CELL BASED COMPOSITIONS AND METHOD FOR TREATING SUFFERING NERVOUS SYSTEM SUFFERING
EP2578206A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISORDERS OF THE LOWER PART OF THE UROGENITAL SYSTEM
GB201219696D0 (en) Agents for the prevention and/or treatment of central nervous system damamge
AU2009900341A0 (en) Method for the treatment of mental disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220407